Cleared Traditional

K130397 - ARROW GPSCATH BALLOON DILATATION CATHETER

K130397 is an FDA 510(k) clearance for ARROW GPSCATH BALLOON DILATATION CATHETER, manufactured by Hotspur Technologies. The device is a Class 2 Cardiovascular device with product code LIT cleared through the Traditional 510(k) pathway after a 121-day FDA review.

K130397 · Hotspur Technologies · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2013
Decision
121d
Days
Class 2
Risk

K130397 is an FDA 510(k) clearance for the ARROW GPSCATH BALLOON DILATATION CATHETER. Classified as Catheter, Angioplasty, Peripheral, Transluminal (product code LIT), Class II - Special Controls.

Submitted by Hotspur Technologies (Mountain View, US). The FDA issued a Cleared decision on June 20, 2013 after a review of 121 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Hotspur Technologies devices

FDA 510(k) Submission Details - K130397

510(k) Number K130397 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 19, 2013
Decision Date June 20, 2013
Days to Decision 121 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
4d faster than avg
Panel avg: 125d · This submission: 121d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LIT Device Classification - Class 2, Special Controls

Product Code LIT Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - LIT Catheter, Angioplasty, Peripheral, Transluminal

All 278
Devices cleared under the same product code (LIT) and FDA review panel - the closest regulatory comparables to K130397.
ADVANCE 34LP LOW PROFILE PTA BALLOON DILATATION CATHETER
K132020 · Cook, Inc. · Oct 2013
STERLING OVER-THE-WIRE (OTW) PTA BALLOON DILATATION CATHETER
K132430 · Boston Scientific Corp · Oct 2013
NANOCROSS ELITE .14 OVER-THE-WIRE PTA, BALLOON DILATION CATHETER
K132777 · Ev3, Inc. · Sep 2013
ADVANCE 18LP LOW PROFILE PTA BALLOON DILATATION CATHETER
K130293 · Cook, Inc. · May 2013
ULTRAVERSE RX PTA BALLOON DILATATION CATHETER
K131199 · Bard Peripheral Vascular, Inc. · May 2013
RAPIDCROSS PTA RAPID EXCHANGE BALLOON DILATATION CATHETER
K130911 · Ev3, Inc. · May 2013